Eliem Therapeutics, Inc. (ELYM)
- Previous Close
4.1800 - Open
4.0400 - Bid 3.7600 x 100
- Ask 3.9200 x 100
- Day's Range
3.6806 - 4.4400 - 52 Week Range
2.3400 - 5.1900 - Volume
451,239 - Avg. Volume
685,993 - Market Cap (intraday)
106.72M - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial. The company was incorporated in 2018 and is headquartered in Redmond, Washington.
eliemtx.comRecent News: ELYM
Performance Overview: ELYM
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELYM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELYM
Valuation Measures
Market Cap
117.81M
Enterprise Value
11.36M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.09
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-0.28
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-10.93%
Return on Equity (ttm)
-29.72%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-35.12M
Diluted EPS (ttm)
-1.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
106.8M
Total Debt/Equity (mrq)
0.32%
Levered Free Cash Flow (ttm)
3.46M
Research Analysis: ELYM
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell